HIF-1 mediates the metabolic response to intratumoral hypoxia and carcinogenic mutations, is activated in cancer cells through the loss of tumor suppressor function and the acquisition of oncogene function, and mediates metabolic changes that lead to cancer progression and therapeutic resistance (33). The gene discussed is HIF1A; the disease is cancer.